Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
Trials|April 16, 2020
Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trialYohei Kamata, Takaomi Kessoku, Tomoko Shimizu, et al.Frontiers in Endocrinology|November 15, 2021
Endotoxins and Non-Alcoholic Fatty Liver DiseaseTakaomi Kessoku, Takashi Kobayashi, Kento Imajo, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 7, 2025
Long-term prognostic outcomes in high-risk T1 colorectal cancer: A multicentre retrospective comparison of surgery versus observation postendoscopic treatmentYosuke Atsumi, Masakatsu Numata, Jun Watanabe, et al.Hepatology (Baltimore, Md.)|December 24, 2021
Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver diseaseNobuyoshi Kawamura, Kento Imajo, Kyle J Kalutkiewicz, et al.Cancers|May 14, 2022
Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled TrialAnna Ozaki, Takaomi Kessoku, Kosuke Tanaka, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 19, 2008
Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysisMasato Yoneda, Hiroki Endo, Hironori Mawatari, et al.Contemporary Clinical Trials Communications|July 11, 2022
Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipationAtsushi Yamamoto, Takaomi Kessoku, Kosuke Tanaka, et al.Journal of Gastroenterology and Hepatology|June 6, 2023
Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populationsSeiji Futagami, Takaomi Kessoku, Yuki Kasai, et al.BMJ Open|May 31, 2022
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipationKosuke Tanaka, Takaomi Kessoku, Atsushi Yamamoto, et al.Scientific Reports|June 25, 2014
PPARβ/δ activation of CD300a controls intestinal immunityToshiya Tanaka, Satoko Tahara-Hanaoka, Tsukasa Nabekura, et al.Pageof 13